ASC-69
PD-1/PD-L1-IN-29 intermediate-2
Emfizatamab
Retifanlimab
Erfonrilimab
Rosnilimab
Peresolimab
Zeluvalimab
Pucotenlimab
Reozalimab
Sudubrilimab
Opucolimab
Sasanlimab
Pimivalimab
Rulonilimab
Prolgolimab
Nofazinlimab
Pacmilimab
Cosibelimab
Socazolimab